|11-08-2018 09:08 PM CET - Advertising, Media Consulting, Marketing Research||
Next-Generation Sequencing Market Briefing by Illumina, Inc. (US), Thermo Fisher Scientific, Inc. (US), Pacific Biosciences of California, Inc. (US), BGI (China), PerkinElmer (US), Agilent Technologies (US), QIAGEN N. V. (Germany), Macrogen Inc. (South Ko
Press release from: Market Research Future
Next-Generation Sequencing Market methods or high throughput sequencing methods deliver a high rate of throughputs that can yield a huge volume of sequences with many applications in clinical research, forensics, agriculture, and others.
Factors such as increasing technological advancements, increasing awareness, growing acquisitions and mergers among the players. to build capital for new innovations and rise in genome mapping programs boost the growth of the market exponentially. However, factors such as infrastructure, skilled workforce to manage and store huge amount of data appropriately, and the high cost involved in the technology, restrain the market from growth.
Some of the key players in the global next-generation sequencing market Illumina, Inc. (US), Thermo Fisher Scientific, Inc. (US), Pacific Biosciences of California, Inc. (US), BGI (China), PerkinElmer (US), Agilent Technologies (US), QIAGEN N. V. (Germany), Macrogen Inc. (South Korea), Oxford Nanopore Technologies, Ltd. (UK), and Eurofins Scientific (Luxembourg).
Avail Sample Copy for this Report Before Purchase: www.marketresearchfuture.com/sample_request/6354
Key players involved in next-generation sequencing data are undergoing strategic alliances in order to grow their current product portfolio, in the meantime maintain a competitive edge in the market. The alliances are basically focused on developing advanced infrastructure solutions thus empowering researchers to perform a population-scale genomic analysis.
The global next generation sequencing market has been segmented on the basis of technology, service and product, application, and end-user.
On the basis of the type of technology, the market has been classified as whole genome sequencing, whole exome sequencing, CHIP sequencing, methyl sequencing, targeted resequencing, RNA sequencing and de novo sequencing.
On the basis of the type of service & product, the market has been classified as sample preparation, consumables, platforms and services for platforms, sequencing services. The sample preparation is segmented into DNA fragmentation, end repair, A-tailing, and size selection, library preparation & target enrichment, and quality control.
The platforms and services for platforms are segmented into Illumina, Thermo Fisher Scientific, Pacific Biosciences, Oxford Nanopore Technologies, and other next-generation sequencing platforms. The illumine is further sub-segmented into hiseq Series, hiseq X ten & hiseq X five, miseq series, nextseq 500, miniseq, and novaseq. The Thermo Fisher Scientific is further sub-segmented into Ion PGM, Ion proton, ion S5 & S5 XL. The Pacific Biosciences is further sub-segmented into pacbio RS II, sequel system. The sequencing services are segmented into exome & targeted re-sequencing and custom panels, RNA-seq, whole-genome sequencing & de novo sequencing.
On the basis of type of application, the market has been classified as drug discovery, genetic screening, diagnostics, agriculture and animal research and others.
On the basis of type of end-users, the market has been academic institutes and research centers, hospitals and clinics, pharmaceutical and biotechnology companies and other end-users.
Advanced Skilled Professionals
Research Institutes and Academic Centers
Market Research and Consulting
Browse Complete 108 Pages Premium Research Report Enabled with 121 Respective Tables and Figures at: www.marketresearchfuture.com/reports/next-generation-sequ...
Global Next Generation Sequencing Market Share, by Region, 2017 (%)
In the next generation sequencing market, North America is anticipated to account for the largest market share. Factors such as a rise in customer requirements and increased competition among players through acquisitions and mergers are anticipated to drive the growth of the market. The rise in the number of funds and initiatives adopted by the government to decrease the cases of cancer and to improve the healthcare sector is likely to grow the market.
The European market is expected to hold the second largest market share due to the presence of pioneering next-generation sequencing technology, a very refined and educated population interested in next-generation technology (NGS). Nevertheless, the diverse rules and regulations and a fragmented market all over Europe are likely to restrain the growth of the market.
The market share in Asia-Pacific is also projected to experience growth in the near future due to access to optimal treatment facilities and growing demand for advanced technology, better adoption rate, increase in disposable income, and rising investments by pharmaceutical companies.
The market in the Middle East and Africa is expected to account for the smallest share of the next generation sequencing market due to an underdeveloped healthcare sector, lack of technical knowledge, and poor medical facilities.
Inquire for Discount at: www.marketresearchfuture.com/check-discount/6354
About Market Research Future: MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar, Pune
+1 646 845 9312
This release was published on openPR.
News-ID: 1357598 • Views: 597More releases